We previously reported that 3 p53 wild type (wt) MYCN amplified (MNA) neuro-blastoma cell lines failed to G1 arrest after DNA damage despite induction of p53, p21WAF1 and MDM2. We hypothesised that this was due to high MYCN expression. p53 responses to DNA damage were examined in an additional 13 p53 wt neuroblastoma cell lines. MNA was significantly associated with a failure to G1 arrest after DNA damage (p < 0.001) and higher levels of apoptosis after irradiation (p <0.05). p21WAF1 and hypophosphorylated (hypo) RB accumulation post irradiation were significantly lower in cell lines that failed to G1 arrest (p < 0.05). Conditional MYCN expression in non-MNASHEP Tet21N cells did not affect the G1 arrest after irradiation. MYCN knockdown...
MYCN amplification occurs in approximately 20% of human neuroblastomas and is associated with early ...
MYCN amplification occurs in approximately 20% of human neuroblastomas and is associated with early ...
Human neuroblastoma is the most common solid tumor affecting children under the age of five. The p53...
MYCN amplification occurs in approximately 25% of neuroblastomas, where it is associated with rapid ...
MYCN amplification occurs in approximately 25% of neuroblastomas, where it is associated with rapid ...
none8siMYCN amplification occurs in approximately 25% of neuroblastomas, where it is associated with...
MYCN amplification is a major biomarker of poor prognosis, occurring in 25-30 % of neuroblastomas. M...
The MYCN oncogene is the major negative prognostic marker in neuroblastoma with important roles in b...
The MYCN oncogene is the major negative prognostic marker in neuroblastoma with important roles in b...
none7The MYCN oncogene is the major negative prognostic marker in neuroblastoma with important roles...
The MYC oncogenes and p53 have opposing yet interrelated roles in normal development and tumorigenes...
The MYC oncogenes and p53 have opposing yet interrelated roles in normal development and tumorigenes...
The MYC oncogenes and p53 have opposing yet interrelated roles in normal development and tumorigenes...
The MYC oncogenes and p53 have opposing yet interrelated roles in normal development and tumorigenes...
MYCN amplification occurs in approximately 20% of human neuroblastomas and is associated with early ...
MYCN amplification occurs in approximately 20% of human neuroblastomas and is associated with early ...
MYCN amplification occurs in approximately 20% of human neuroblastomas and is associated with early ...
Human neuroblastoma is the most common solid tumor affecting children under the age of five. The p53...
MYCN amplification occurs in approximately 25% of neuroblastomas, where it is associated with rapid ...
MYCN amplification occurs in approximately 25% of neuroblastomas, where it is associated with rapid ...
none8siMYCN amplification occurs in approximately 25% of neuroblastomas, where it is associated with...
MYCN amplification is a major biomarker of poor prognosis, occurring in 25-30 % of neuroblastomas. M...
The MYCN oncogene is the major negative prognostic marker in neuroblastoma with important roles in b...
The MYCN oncogene is the major negative prognostic marker in neuroblastoma with important roles in b...
none7The MYCN oncogene is the major negative prognostic marker in neuroblastoma with important roles...
The MYC oncogenes and p53 have opposing yet interrelated roles in normal development and tumorigenes...
The MYC oncogenes and p53 have opposing yet interrelated roles in normal development and tumorigenes...
The MYC oncogenes and p53 have opposing yet interrelated roles in normal development and tumorigenes...
The MYC oncogenes and p53 have opposing yet interrelated roles in normal development and tumorigenes...
MYCN amplification occurs in approximately 20% of human neuroblastomas and is associated with early ...
MYCN amplification occurs in approximately 20% of human neuroblastomas and is associated with early ...
MYCN amplification occurs in approximately 20% of human neuroblastomas and is associated with early ...
Human neuroblastoma is the most common solid tumor affecting children under the age of five. The p53...